Stay updated on Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial page.

Latest updates to the Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov record for the azeliragon Alzheimer’s disease study is displayed with its study details, eligibility criteria, locations, and outcomes, replacing a 403 error page.SummaryDifference79%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA banner announces an NIH-wide transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The page continues to display a 403 error instead of the study record.SummaryDifference1%

- Check39 days agoChange DetectedThe site revision identifier in the page footer changed from v3.7.0 to v3.7.1, while the study record continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page’s revision label was updated from v3.6.6 to v3.7.0, indicating a system update. This change does not modify trial details, outcomes, or eligibility requirements.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, signaling a small maintenance update to the page version without altering the study information.SummaryDifference0.0%

Stay in the know with updates to Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial page.